JSSH
RANI icon

J. Safra Sarasin Holding’s Rani Therapeutics RANI Stock Holding History

J. Safra Sarasin Holding’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Buy
+17,000
New +$15.1K ﹤0.01% 796

Other funds holding RANI

KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WDL
Well Done LLC Holland, Michigan $743M AUM 22.58% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

J. Safra Sarasin Holding's RANI Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in Rani Therapeutics (RANI) in Q2 2026: 17,000 shares worth $12.9K. The stake represents ﹤0.01% of the portfolio and ranks #796 among its holdings.

13 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • J. Safra Sarasin Holding held 17,000 shares of Rani Therapeutics worth $12.9K as of Q2 2026.
  • Rani Therapeutics was a new J. Safra Sarasin Holding position in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #796 holding.
  • 13 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.